NANOPARTICLES FOR USE FOR TREATMENT OF NEUROLOGICAL DISORDER Russian patent published in 2022 - IPC A61K33/24 A61K33/38 A61K33/242 A61K33/243 A61K33/244 A61K33/44 A61K33/08 A61K9/14 A61K9/16 A61P25/00 

Abstract RU 2779758 C2

FIELD: medicine.

SUBSTANCE: use of a nanoparticle or an aggregate of nanoparticles for the prevention or treatment of a neurological disease or at least one of its symptoms in a subject without affecting the nanoparticle or the aggregate of nanoparticles with an electric field or any other external source of activation is disclosed. Material of the nanoparticle or the aggregate of nanoparticles is selected from conductive material selected from Tl, Po, Ag, Pd, Ir, Pt, and/or Au and organic material having adjacent sp2-hybridized carbon centers in its structure; and insulating material selected from Al2O3, LaAlO3, La2O3, SiO2, SnO2, Ta2O5, ReO2, ZrO2, HfO2, and diamond-like carbon. In this case, i) a median size of a core of the nanoparticle or the aggregate of nanoparticles of a population is at least 30 nm, when material is conductive material, and ii) the core of the nanoparticle or the aggregate of nanoparticles is coated with biocompatible coating, iii) biocompatible coating providing a negative surface charge is selected from phosphate, dicarboxylic acid, succinic acid, or sulfate, and biocompatible coating providing a neutral surface charge is selected from an agent including a functional group selected from alcohol (R-OH), aldehyde (R-COH), ketone (R-CO-R), composite ester (R-COOR), acid (R-COOH), thiol (R-SH), saccharide, anhydride (RCOOOC-R), and pyrrole. The use of a composition including the above-described particles and/or aggregates of nanoparticles, and a pharmaceutically acceptable carrier for the prevention or treatment of a neurological disease or at least one of its symptoms in a subject are also disclosed.

EFFECT: group of inventions provides prevention or treatment of a neurological disease or at least one of its symptoms without affecting a nanoparticle or an aggregate of nanoparticles with an electric field.

6 cl, 21 dwg, 8 tbl, 13 ex

Similar patents RU2779758C2

Title Year Author Number
NANOPARTICLES FOR USE IN INCREASING BRAIN WORKING CAPACITY OR IN STRESS TREATMENT 2018
  • Pottier, Agnes
  • Levy, Laurent
  • Meyre, Marie-Edith
RU2782384C2
COMPOSITION BASED ON NANOPARTICLES WITH IMPROVED PENETRATION THROUGH MUCOUS MEMBRANES 2013
  • Ensajn Lora
  • Koun Richard
  • Khejns Dzhastin Skot
RU2598627C2
RESTORATION OF THE SENSORIMOTOR FUNCTION USING A NEUROPROSTHETIC SYSTEM AND METHOD FOR IMPLEMENTATION THEREOF 2020
  • Lavrov Igor Alexandrovich
  • Talanov Maxim Olegovich
  • Toshchev Aleksandr Sergeevich
  • Kuptsov Andrey Pavlovich
RU2772637C2
PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION 2011
  • Park Cheol Kheung
  • Min Khie Kiung
  • Park In Suk
  • Lim Mi Dzung
  • Li Dzi Vong
  • Chung Dzin Jong
  • Joon Jeo Dzin
  • Park Dzoo Yang
RU2586772C2
ISOINDOLINE COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISEASE 2015
  • Rishton Gilbert
  • Katalano Syuzan M.
  • Luk Geri K.
RU2692258C2
PEPTIDE CONJUGATED PARTICLES 2014
  • Shea, Lonnie D
  • Miller, Stephen D.
  • Yap, Jonathan Woon Teck
  • Getts, Daniel R.
  • Mccarthy, Derrick
RU2685186C2
NON-MEDUCATIONAL METHOD OF TREATMENT OF ADYNAMIC DEPRESSIONS 2022
  • Neliubova Elena Sergeevna
  • Shmilovich Andrei Arkadevich
  • Kolsanov Aleksandr Vladimirovich
RU2801161C1
DONECOPRID AS A NEUROPROTECTIVE AGENT IN THE TREATMENT OF NEURODEGERATIVE DISEASES 2019
  • Dallemagne, Patrick
  • Rochais, Christophe
  • Claeysen, Sylvie
RU2800802C2
USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) 2017
  • Kerkis, Irina
  • Valverde Ventseslau, Kristian
RU2742828C2
USE OF A BENZOPYRAN DERIVATIVE FOR THE TREATMENT OF DEMENTIA OF ALZHEIMER'S TYPE ASSOCIATED WITH CALCIUM DYSREGULATION 2023
  • Zernov Nikita
  • Melenteva Daria Maksimovna
  • Bolshakova Anastasiia Viktorovna
  • Popugaeva Elena Aleksandrovna
RU2804398C1

RU 2 779 758 C2

Authors

Meyre, Marie-Edith

Levy, Laurent

Pottier, Agnes

Dates

2022-09-13Published

2018-12-18Filed